Behandling af svaer aktiv morbus Crohn med adalimumab
Engelsk titel: The use of adalimumab in severe Crohn's disease
Läs online
Författare:
Bang UC
;
Mertz Nielsen A
Email: ulrich_bang@dadlnet.dk
Språk: Dan
Antal referenser: 4
Dokumenttyp:
Fallbeskrivning
UI-nummer: 08061371
Sammanfattning
So far infliximab is the only approved anti-TNF-a antibody for patients with Crohn's disease. Development of antibodies to infliximab may result in allergic reactions or reduced effect. We report three patients who received adalimumab, which induced longstanding remission in all three patients.